23 May 2013
Keywords: losartan, approved, uk, hypertension, merck, co, subsidiary
Article | 16 January 1995
Merck & Co's UK subsidiary Merck Sharp & Dohme has received approval to
market its new angiotensin II receptor antagonist, Cozaar (losartan) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 January 1995
22 May 2013
© 2013 thepharmaletter.com